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Agonist-induced degradation ofphosphatidylcholine (PC) is of interest as this pathway of diacylglycerol (DG) generation 
may provide added opportunities for the regulation of protein kinase C (PKC). In REF52 cells pH]myristic acid is prefe- 
rentially incorporated into PC; this, coupled with the use of pH]eholine, allows for quantitation of both the water-soluble 
and the lipid products generated when PC is degraded. In cells prelabeled with pH]choline, TPA stimulated a time-depen- 
dent release, into the medium, of choline and not phosphocholine orglycerophosphocholine. Tr atment of pH]myristic 
acid-labeled cells with either phorbol diesters, sn-1,2-dioetanoyiglycerol, or vasopressin elicited the formation of labeled 
phosphatidate (PA) and DG. The temporal pattern of PC hydrolysis in cells treated with TPA is indicative of a precursor 
(PA)-product (DG) relationship for an enzymatic sequence initiated by phospholipase D. Adding propranolol, a phos- 
phatidate phosphohydrolase inhibitor, eliminated TPA-induced DG formation, whereas PA generation was unaffected. 
From these data we conclude that TPA elicits DG formation from PC by the sequential ctions of phospholipase D 
and phosphatidate phosphohydrolase. 
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1. INTRODUCTION 
The action of many cellular agonists is transmit- 
ted via a receptor-mediated r sponse that elicits 
phosphoinositide hydrolysis by a PIPE-specific 
phospholipase C [1]. This reaction yields DG and 
inositol phosphates, which together activate PKC 
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Abbreviations: PIP2, phosphatidylinositol 4,5-bisphosphate; 
DG, diacylglycerol; PKC, CaZ+-activated, phospholipid- 
dependent protein kinase C; TPA, 12-O-tetradecanoylphorbol- 
13-acetate; PC, phosphatidylcholine; BSA, bovine serum 
albumin; VP, vasopressin; PA, phosphatidate; TLC, thin-layer 
chromatography. In the naming of PC, PA and DG we do not 
distinguish between the type of aliphatic linkage to glycerol 
(ester, ether) 
[2,3]. TPA, because of its metabolic stability and 
structural analogy to DG, circumvents the PIPE 
pathway of DG generation and interacts directly 
with PKC [4,5]. TPA has therefore been a valuable 
tool for investigating the cellular aspects of PKC 
activation. The classical scheme involving PIPE as 
the sole source of DG second messengers has 
recently been challenged. New research as reveal- 
ed a cellular pathway for the agonist-induced 
generation of DG from PC [6-9]; however, the en- 
zymatic avenue of DG formation has not been 
clarified. 
In a previous tudy we have shown that serum, 
VP and TPA induce PC degradation and the col- 
lateral formation of DG in cultured REF52 cells 
[9]. Cell treatment was accompanied by the release 
of [3Hlcholine to the culture medium [9], sug- 
gesting that phospholipase D was the initial en- 
zyme involved in the evolution of DGs. The study 
of PC degradation in cultured cells has been 
hindered due to a lack of precursors that are 
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specific for labeling the al iphatic port ion of  the 
molecule. In this work we have employed 
[3H]myristic acid, which is preferential ly incor- 
porated into PC of  REF52 cells, to determine the 
enzymatic sequence of  events responsible for phor-  
bol diester- induced format ion of  DG. Our study 
indicates that DGs arise from PC via the initial ac- 
t ion of  phosphol ipase D. 
2. MATERIALS  AND METHODS 
2.1. Materials 
[9,10(N)-3H]Myristic a id (41 Ci/mmol) was purchased from 
Amersham, and [methyl-3Hlcholine chloride (80 Ci/mmol) was 
from New England Nuclear. TPA was purchased from 
Chemicals for Cancer Research (Eden Prairie, MN). Pro- 
pranolol, cell culture media and VP were purchased from 
Sigma. Silica gel G TLC plates were from Analtech, Inc. 
(Newark, DE), and solvents were purchased from Burdick & 
Jackson and J.T. Baker. Fetal bovine serum was from Hy- 
Clone (Logan, UT). Lipid standards for TLC were purchased 
from Avanti Polar Lipids (Birmingham, AL) and Nu Chck 
Prep (Elysian, MN). 
2.2. Cell culture, radiolabeling, and treatment 
The rat embryo-derived cell line, REF52, provided by Dr 
D.B. McClure (Division of Molecular and Cellular Biology, Eli 
Lilly and Company, Indianapolis, IN), was cultured as 
previously described [9-11]. Cells were used at passages 5
through to 15. 
Confluent monolayers were rinsed twice in serum-free 
medium before addition of isotopes. Cells were labeled for 
60min with [3H]myristic acid (0.5-1.0/~Ci/ml serum-free 
medium containing 0.1 mg BSA per ml, designated medium A). 
After removal of isotope, monolayers were rinsed twice in 
serum-free medium containing 1.0 mg BSA/ml (medium B), 
and incubated in the same for 60 min. Following one rinse with 
medium B, TPA and VP were added in medium B. TPA (8 x 
10 -8 M) was added as previously described [9]; VP (100 ng/ml) 
was added in 0.05 N acetic acid. Cells were prelabeled with 
[3H]choline (1.0/zCi/ml medium) for 48 h and then prepared 
for experiments a  described above. 
2.3. Lipid analysis 
Total cellular lipids were extracted by a modified [9] Bligh 
and Dyer [12] procedure. For [3H]myristic acid-labeled ex- 
periments, neutral lipids and phospholipids (with the exception 
of PA) were resolved by TLC using the solvent systems de- 
scribed previously [9]. PA was resolved in a solvent system con- 
taining chloroform/pyridine/70% formic acid (50: 30: 7, v/v). 
The individual lipids, cochromatographed withstandards, were 
visualized in iodine vapor and radioactivity was determined by 
liquid scintillation spectrometry [13]. Plates run in the pyridine 
system were left under the fume hood overnight and lipids were 
visualized the next day. [3H]Choline-labeled metabolites re- 
leased into the medium were identified by TLC and quantitated 
as described [9]. 
3. RESULTS 
Approx .  40~70 of  the [3H]myristic acid added to 
the culture medium was taken up by REF52 cells 
after 60 min. The distr ibut ion of  radioact iv i ty in 
cellular l ipids is shown in table 1; PC accounted 
for 82°7o of  the total.  Phosphol ip id  radioact iv i ty 
accounted for approx.  90% of  the total ,  and of  
this, the major i ty  of  [3H]myristate (>90°)  was 
localized in the PC fraction. 
PC hydrolysis was studied by analysis of  both 
hydrophi l ic  and hydrophobic  degradat ion prod-  
ucts. In cells prelabeled with [3H]choline, TPA 
treatment caused a t ime-dependent release of  
water-soluble [3H]choline-containing metabol i tes 
into the medium, that by 60 min was approx.  
4-fold higher than in control  cells ( f ig. l ,  inset). 
Analysis of  the radioact iv i ty released showed that 
the increase licited by TPA was due mainly to an 
increase in [3H]choline ( f ig . l ,  left panel) and that 
although TPA caused an increase in phospho-  
choline release (middle panel), the contr ibut ion to 
the total  was not signif icant (<4%) .  Tr i t ium in 
g lycerophosphochol ine was not altered by TPA 
treatment.  Therefore,  the data in fig. 1 remained 
unaltered. Therefore,  the data in fig. 1 reveal that 
-96% of  the TPA- induced release of  tr i t ium is in 
the form of  [3H]choline. As hydrolysis of  the 
choline moiety should be accompanied by the for- 
mat ion of  PA ,  cells prelabeled with [3H]myristic 
Table 1 
Distribution of [3H]myristic acid in total ipids of REF52 cells 
Cellular lipids Incorporation 
(% of total 3H) 
Lysophosphatidylcholine 0.5 
Sphingomyelin 2.0 
Phosphatidylcholine 82 
Inositol plus serine phospholipids 1.0 
Phosphatidylethanolamine 4.0 
Monoacylglycerol 1.0 
Diacylglycerol 0.9 
Fatty acid 0.5 
Triacylglycerol 6.0 
Cholesterol ester 1.0 
Cells were labeled with [3H]myristic acid (0.5/~Ci/ml) for 
60 min, and total ipids were extracted, resolved, and analyzed 
for tritium as detailed in section 2. Data represent the mean of 
triplicate cultures 
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Fig. 1. TPA elicits a time-dependent release of choline in REF52 cells. Cultures were prelabeled with [3H]choline and incubated in the 
absence (e) or presence of TPA (o), 8 x 10 -s M, for the times shown. The tritium released into the medium was analyzed as 
described in section 2.3. Inset shows total water-soluble radioactivity released. Incubations were performed in duplicate; repeated 
experiments gave identical results. Cho, choline; PhoCho, phosphocholine; GroPhoCho, glycerophosphocholine. 
acid were used to assay the evolut ion of  
[3H]myristoyl-PA.  
The data in table 2 demonstrate that two 
agonists, which st imulate PKC directly, elicit the 
format ion o f  [3H]myristoyl-PA. TPA and DiC8 
treatment caused a 5.2- and 6.7-fold increase in 
[3H]PA, respectively. TPA and DiC8 treatment 
Table 2 
Agonist treatment elicits PC hydrolysis and formation of 
phosphatidate and diacylglycerols in REF52 cells 
Cell treatment cpm lipid 3H/culture (+ SD) 
PA DG 
Control I l l5 ± 35 3050 ± 90 
TPA (8 x 10 -s  M) 5770 ± 230 7605 ± 330 
DiC8 (7.5 x l0 -5 M) 7445 ± 140 6090 + 315 
Control 281 ± 48 1311 + 59 
VP (100 ng/ml) 731 ± 94 3182 ± 97 
Cells, prelabeled with [~H]myristic acid, were incubated ± 
agonists for 10 min. Lipids were analyzed as described in 
section 2. n = 3 for the TPA and DiC8 series; n = 5 for the VP 
experiments. The VP experiments were carried out in smaller 
culture dishes, hence the lower labeling values 
also st imulated a 2.5- and 2.0-fold increase in DG 
(table 2). Treatment  with VP caused similar 
responses. The temporal  pattern of  TPA- induced 
PC hydrolysis is i l lustrated in fig.2. The data 
(fig.2, inset) show that PC hydrolysis is accom- 
panied by the initial format ion o f  PA,  and the for- 
mat ion o f  DG fol lows. Fig.2 shows that PA  and 
DG radioact iv i ty in untreated cultures was relative- 
ly stable throughout  the 15-min incubat ion period. 
However,  in TPA-exposed cells, the format ion of  
[3H]PA was rapid and exceeded that o f  DG at early 
times. The addit ion of  unlabeled myrist ic acid 
(9/~M), either during the 60 min chase (post- 
labeling) or at the t ime of  TPA addit ion,  had no 
inf luence on the format ion o f  [3H]PA or [3H]DG. 
The kinetics for the format ion o f  [~H]myristoyl- 
DG indicate that the DG is derived f rom PA.  To 
verify this point,  cells were pre incubated with pro- 
pranolol ,  a phosphat idate phosphohydro lase in- 
hibitor [14]. Pre l iminary experiments showed that 
100/zM propranolo l  was sufficient to block TPA-  
induced DG format ion.  The data in fig.3 show the 
t ime course for this response. Proprano lo l  severely 
depressed the TPA-el ic i ted product ion of  DG, 
whereas PA  generat ion proceeded. 
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Fig.2. TPA-induced PC hydrolysis proceeds via rapid 
formation of phosphatidate and subsequent generation of 
diacylglycerol. Cultures were prelabeled with [3H]myristic acid 
and incubated in the absence of (control) or presence of TPA 
(8 × 10 -s M) for the times hown. Data points are cpm/culture 
and are the average of triplicate cultures (SD < 10% of mean). 
Data from three other experiments gave similar results. 
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Fig.3. The influence of propranolol on TPA-induced PC 
degradation i  REF52 cells. Cultures were prelabeled with 
[3H]myristic acid and preincubated with propranolol (100/~M, 
3 rain) before the addition of TPA (8 x 10 -8 M) for the times 
indicated. Cellular [3H]PA and [3H]DG were analyzed as 
described (section 2.3). Data points are the averages of 2-3 
cultures (variation < 10%); repeated experiments gave similar 
results. 
VP-induced PC hydrolysis, assessed by 
[3H]choline and [3H]myristic acid labeling techni- 
ques, was similar to that evoked by TPA. With VP 
treatment, he release of [3H]choline and forma- 
tion of intracellular [~H]PA occurred early on 
(measurable at 1 min) and [3H]DG formation 
followed (not shown). 
4. DISCUSSION 
Phorbol diester-induced PC degradation has 
been suggested to occur via the action of cellular 
phospholipase C [7,8,15,16]. In REF52 cells we 
have demonstrated that phospholipase D is the in- 
itial lipolytic event in TPA-induced breakdown of 
PC. A phospholipase D-related pathway for PC 
hydrolysis was suggested in the work of Liscovitch 
et al. [17] who found a preponderance of choline 
release in NG108-15 cells treated with TPA. The 
relationship of the two pathways of PC degrada- 
tion, the phospholipase D pathway and the 
phospholipase C pathway is presently not known. 
As suggested previously [9], it is possible that the 
importance of a particular phospholipase is a func- 
tion of the cell type and/or agonist used. In work 
similar to our TPA studies, Bocckino et al. [18] 
have shown that phosphatidate accumulation i
hormone-treated hepatocytes occurs via a 
phospholipase D mechanism. Our data with VP 
action on REF52 cells are in agreement. In work 
submitted (Cabot, M.C., Welsh, C.J., Zhang, Z. 
and Cao, H., Evidence for a protein kinase C- 
directed mechanism in agonist-induced 
diacylglycerol generation from phosphatidylcho- 
line), we have shown evidence that PC degradation 
in REF52 cells occurs via a PKC-directed 
mechanism. 
Most of what is known of mammalian 
phospholipase D comes from the work of Witter 
and Kanfer [19]. Our results which implicate a 
phospholipase D pathway for PC degradation are 
based on: (i) cellular release of [3H]choline; (ii) 
rapid intracellular formation of [3H]PA followed 
by [3H]DG; (iii) blocking of [3H]DG formation by 
propranolol. Others have shown, as we have, that 
phospholipase D is hormone-inducible [9,18]. It is 
interesting to note that agonist-induced PC 
hydrolysis i severely depressed or totally absent in 
several transformed erivatives of the parent 
REF52 cell line [9]. As the action of phospholipase 
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D results in the formation of PA, a proported 
second messenger [20,21], and DG, a known ac- 
tivator of PKC [3], it is tempting to speculate that 
phospholipase D plays a role in cellular egulation. 
In addition to REF52 cells we have recently 
demonstrated a similar VP-induced phospholipase 
D pathway in vascular smooth muscle cells [22|, 
and it is in smooth muscle cells that PA is thought 
to function as a second messenger [20]. 
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